| P50 | author | Mario Maj | Q17306224 |
| P2093 | author name string | Stephen M Strakowski | |
| | David E Fleck | |
| P2860 | cites work | The genetics of bipolar disorder | Q22251249 |
| | Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication | Q22253024 |
| | The Heritability of Bipolar Affective Disorder and the Genetic Relationship to Unipolar Depression | Q22253037 |
| | Effectiveness of adjunctive antidepressant treatment for bipolar depression | Q28295408 |
| | Validity and utility of bipolar spectrum models | Q37058587 |
| | Association between bipolar spectrum features and treatment outcomes in outpatients with major depressive disorder. | Q37224904 |
| | The bipolar spectrum--a bridge too far? | Q37352345 |
| | Meta-analyses of mood stabilizers, antidepressants and antipsychotics in the treatment of borderline personality disorder: effectiveness for depression and anger symptoms | Q37451580 |
| | The bipolar spectrum: a critical perspective | Q37508848 |
| | Searching genetic risk factors for schizophrenia and bipolar disorder: learn from the past and back to the future | Q37559492 |
| | Where should bipolar disorder appear in the meta-structure? | Q37606631 |
| | Lithium's emerging role in the treatment of refractory major depressive episodes: augmentation of antidepressants | Q37746778 |
| | Understanding schizoaffective disorder: from psychobiology to psychosocial functioning | Q37824502 |
| | Are bipolar II patients cognitively impaired? A systematic review | Q37833020 |
| | Heterogeneity of DSM-IV major depressive disorder as a consequence of subthreshold bipolarity | Q39921117 |
| | The Latest Developments in the MATRICS Initiative | Q40258762 |
| | Diagnosis in schizophrenia and manic-depressive illness: a reassessment of the specificity of 'schizophrenic' symptoms in the light of current research | Q40919104 |
| | Decreased brain serotonin transporter binding in the euthymic state of bipolar I but not bipolar II disorder: a SPECT study | Q43011125 |
| | Venlafaxine monotherapy in bipolar type II depressed patients unresponsive to prior lithium monotherapy | Q43289055 |
| | A double-blind, randomized, prospective evaluation of the efficacy and safety of risperidone versus haloperidol in the treatment of schizoaffective disorder | Q43689712 |
| | Olanzapine versus haloperidol in schizoaffective disorder, bipolar type | Q43899264 |
| | The mood spectrum in unipolar and bipolar disorder: arguments for a unitary approach | Q44498201 |
| | Lower switch rate in depressed patients with bipolar II than bipolar I disorder treated adjunctively with second-generation antidepressants | Q46055681 |
| | Toward a validation of a new definition of agitated depression as a bipolar mixed state (mixed depression). | Q46195839 |
| | A simulated genetic structure for bipolar illness | Q46722414 |
| | Prevalence and correlates of eating disorders in 875 patients with bipolar disorder | Q47608187 |
| | Regional brain gray matter abnormalities in patients with bipolar II disorder: a comparison study with bipolar I patients and healthy controls | Q48622372 |
| | Frequency of manic symptoms during a depressive episode and unipolar 'depressive mixed state' as bipolar spectrum. | Q51028056 |
| | Psychiatric diagnoses in patients who screen positive on the Mood Disorder Questionnaire: Implications for using the scale as a case-finding instrument for bipolar disorder. | Q51847519 |
| | Clinical characteristics of depressed outpatients previously overdiagnosed with bipolar disorder. | Q51855996 |
| | A consecutive series of treated affected offspring of parents with bipolar disorder: is response associated with the clinical profile? | Q51900534 |
| | Impulsivity and phase of illness in bipolar disorder. | Q51951356 |
| | A plea for integrity of the bipolar disorder concept. | Q53493341 |
| | Identifying "paradigm failures" contributing to treatment-resistant depression. | Q53853658 |
| | Distinct profiles of neurocognitive function in unmedicated unipolar depression and bipolar II depression. | Q54128765 |
| | Agitated "unipolar" major depression: prevalence, phenomenology, and outcome | Q79907691 |
| | Psychiatric diagnoses in patients previously overdiagnosed with bipolar disorder | Q84329424 |
| | Animal models of neuropsychiatric disorders | Q29619899 |
| | The role of cyclothymia in atypical depression: toward a data-based reconceptualization of the borderline-bipolar II connection | Q30758799 |
| | Boundaries of schizophrenia | Q30784001 |
| | Brain network dysfunction in bipolar disorder. | Q31038262 |
| | The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings | Q33206291 |
| | Is borderline personality disorder part of the bipolar spectrum? | Q33206883 |
| | Clinical presentation of mania compared with depression: data from a geriatric clinic in India | Q33459575 |
| | Functional neuroimaging studies of bipolar disorder: examining the wide clinical spectrum in the search for disease endophenotypes. | Q33550538 |
| | An overview of the treatment of schizoaffective disorder | Q33587567 |
| | Comparison of manic and depressive symptoms between children and adolescents with bipolar spectrum disorders | Q33686094 |
| | Controversies concerning the diagnosis and treatment of bipolar disorder in children | Q33758856 |
| | The role of bipolarity in depression in the family practice setting | Q33768249 |
| | Borderline personality disorder and the misdiagnosis of bipolar disorder | Q33770952 |
| | Efficacy and mood conversion rate of short-term fluoxetine monotherapy of bipolar II major depressive episode | Q33950999 |
| | Revised prevalence estimates of mental disorders in the United States: using a clinical significance criterion to reconcile 2 surveys' estimates | Q33957179 |
| | Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study | Q33959019 |
| | The soft bipolar spectrum redefined: focus on the cyclothymic, anxious-sensitive, impulse-dyscontrol, and binge-eating connection in bipolar II and related conditions | Q33962900 |
| | The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases | Q33963449 |
| | Validity of the mood disorder questionnaire: a general population study | Q34167575 |
| | Resilience under conditions of extreme stress: a multilevel perspective | Q34169070 |
| | Role of paliperidone extended-release in treatment of schizoaffective disorder | Q34184199 |
| | Comparative efficacy and tolerability of drug treatments for bipolar disorder | Q34387550 |
| | The emergence of the bipolar spectrum: validation along clinical-epidemiologic and familial-genetic lines. | Q34587684 |
| | The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania | Q34606256 |
| | The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression | Q34616633 |
| | The genetic deconstruction of psychosis | Q34634774 |
| | Dialectical behavior therapy for borderline personality disorder | Q34666797 |
| | Neurocognitive profiles in bipolar I and bipolar II disorder: differences in pattern and magnitude of dysfunction | Q34749753 |
| | Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis | Q34994544 |
| | Difficult-to-treat depressions: a primary care perspective. | Q35081162 |
| | Major depressive disorder with subthreshold bipolarity in the National Comorbidity Survey Replication | Q35132693 |
| | The feasibility of neuropsychological endophenotypes in the search for genes associated with bipolar affective disorder | Q35760290 |
| | Searching for behavioral indicators of bipolar II in patients presenting with major depressive episodes: the "red sign," the "rule of three" and other biographic signs of temperamental extravagance, activation and hypomania | Q36039804 |
| | Increased impulsivity associated with severity of suicide attempt history in patients with bipolar disorder | Q36246218 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bipolar disorder | Q131755 |
| P304 | page(s) | 181-186 | |
| P577 | publication date | 2011-10-01 | |
| P1433 | published in | World Psychiatry | Q8036083 |
| P1476 | title | Broadening the diagnosis of bipolar disorder: benefits vs. risks | |
| P478 | volume | 10 | |